LEADER 00975nam0-2200337---450- 001 990008498600403321 005 20160909105539.0 010 $a88-513-0044-5 035 $a000849860 035 $aFED01000849860 035 $a(Aleph)000849860FED01 035 $a000849860 100 $a20070404d2002----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aTesto unico e regolamenti edilizi$ei nuovi regolamenti edilizi alla luce del D.P.R. n.380/2001 e della L.n.443/2001$fAlessandro Monaco 210 $aNapoli$cEsselibri-Simone$dc2002 215 $a426 p.$d24 cm 610 0 $aRegolamenti 676 $a348 700 1$aMonaco,$bAlessandro$0343100 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008498600403321 952 $a08 AA 701$b1420$fDINED 952 $aP II 08$bs.i.$fDINST 959 $aDINED 959 $aDINST 996 $aTesto unico e regolamenti edilizi$9731463 997 $aUNINA LEADER 01119nam 2200289z- 450 001 9910689550003321 005 20161209101842.0 035 $a(CKB)5860000000020052 035 $a(BIP)008101421 035 $a(EXLCZ)995860000000020052 100 $a20220406c2002uuuu -u- - 101 0 $aeng 200 10$aCorporate accounting practices $eis there a credibility GAAP? : hearings before the Subcommittee on Capital Markets, Insurance, and Government Sponsored Enterprises of the Committee on Financial Services, U.S. House of Representatives, One Hundred Seventh Congress, second session, May 1, 14, 2002 215 $a1 online resource (vi, 294 p.) 311 $a0-16-069011-0 517 $aCorporate accounting practices 606 $aCorporations$zUnited States$xAccounting 606 $aAccounting$xStandards$zUnited States 610 $aCorporations 610 $aAccounting 610 $aBusiness & economics 615 0$aCorporations$xAccounting. 615 0$aAccounting$xStandards 906 $aBOOK 912 $a9910689550003321 996 $aCorporate accounting practices$93202235 997 $aUNINA LEADER 02766nam 22004455 450 001 9910847579103321 005 20250807145729.0 010 $a981-9971-33-0 024 7 $a10.1007/978-981-99-7133-6 035 $a(CKB)31403815600041 035 $a(MiAaPQ)EBC31267349 035 $a(Au-PeEL)EBL31267349 035 $a(DE-He213)978-981-99-7133-6 035 $a(EXLCZ)9931403815600041 100 $a20240409d2024 u| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aClinical Anatomy of the Face for Filler and Botulinum Toxin Injection /$fby Hee-Jin Kim, Kyle K. Seo, Hong-Ki Lee, Ji-Soo Kim, Kwan-Hyun Youn 205 $a2nd ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (191 pages) 311 08$a981-9971-32-2 327 $aChapter 1. Anatomy of the face -- Chapter 2. Clinical anatomy for Botulinum toxin -- Chapter 3. Filler Anatomy of the Upper Face -- Chapter 4. Filler Anatomy of the Midface -- Chapter 5. Filler Anatomy of the Lower Face. 330 $aIn the second edition of this highly successful book, the authors once again aim to equip the reader with up-to-date information. This book, containing more than 200 cadaveric photos and 200 illustrations, aims to familiarize physicians practicing botulinum neurotoxin type A (BoNT-A) and filler injection with the anatomy of the facial mimetic muscles, vessels, and soft tissues in order to enable them to achieve optimum cosmetic results while avoiding possible adverse events. Anatomic considerations of importance when administering BoNT-A and fillers are identified and in addition invaluable clinical guidelines are provided, highlighting, for example, the preferred injection points for BoNT-A and the adequate depth of filler injection. Unique insights are also offered into the differences between Asians and Caucasians with regard to relevant anatomy. The contributing authors include an anatomist who offers distinctive anatomic perspectives on BoNT-A and filler treatments and three expert physicians from different specialties, namely a dermatologist, a plastic surgeon, and a cosmetic physician, who share insights gained during extensive clinical experience in the use of BoNT-A and fillers. 606 $aDermatology 606 $aDermatology 615 0$aDermatology. 615 14$aDermatology. 676 $a615.329364 700 $aKim$b Hee-Jin$0910566 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910847579103321 996 $aClinical Anatomy of the Face for Filler and Botulinum Toxin Injection$92518135 997 $aUNINA